Medications

1990s trial gave early danger signs for asthma drugs

The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.

Inflammatory disorders

Severe allergic asthma linked to gene variation

(Medical Xpress)—A new study from the University of Alberta shows that your genes could be the reason your allergic asthma or hay fever is so severe.

Oncology & Cancer

New drug shrinks brain tumours in melanoma patients

(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.

Medications

US says Teva antidepressant is ineffective

(AP)—Teva Pharmaceuticals has stopped shipping its generic version of a popular antidepressant off the market after a U.S. government analysis showed the pill does not work properly.

Other

Human Genome agrees to GlaxoSmithKline takeover (Update)

(AP) — U.K. drug maker GlaxoSmithKline has secured its takeover of longtime partner Human Genome Sciences after agreeing to pay more, a move to expand GSK's drug portfolio in crucial areas: biologic drugs and treatments ...

Oncology & Cancer

New melanoma drug may extend survival

(HealthDay) -- New research suggests that a new drug does a better job of combating advanced skin cancer in melanoma patients than chemotherapy.

Diseases, Conditions, Syndromes

Sumatriptan/Naproxen helpful in treating teens' migraines

(HealthDay) -- Treatment with sumatriptan and naproxen sodium (suma/nap) is well tolerated and effective in reducing migraine pain in adolescents, according to a study published online May 14 in Pediatrics.

page 5 from 18